Global Clinical Trial Supply & Logistics Market Projects
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The
Source: globenewswire.com
📰 Small Molecules News
Page 3 - Small Molecules News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Small Molecules. Real-time updates on events, politics, business and more.
New molecule targets key protein in autoimmune diseases
Scientists from Scripps Research have developed a small molecule that blocks the activity of a protein linked to autoimmune diseases, including systemic lupus erythematosus (SLE) and Crohn's disease.
Bruce Beutler John Teijaro Christopher Parker University Of Texas Southwestern Medical Center Genetics At Scripps Research Scripps Research
Source: news-medical.net
Global Clinical Trial Supplies Markets 2023-2028: Biologics and Biosimilars Gain Traction, Specialized Testing Services in High Demand
/PRNewswire/ -- The "Global Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics), Phases, Type (Small Molecules, Biologics),...
Source: prnewswire.com
Small molecule-switchable RNA platform enables control of therapeutic protein expression
Just like a doctor adjusts the dose of a medication to the patient's needs, the expression of therapeutic genes, those modified in a person to treat or cure a disease via gene therapy, also needs to be maintained within a therapeutic window.
Yan Wang Jocelyn Duen Ya Jea Pei Wen Chao Department Of Pathology Doctoral Fellowship For Biomedical Research Baylor College Of Medicine
Source: news-medical.net
New method designs high-affinity, orally bioavailable peptides
For decades, a substantial number of proteins, vital for treating various diseases, have remained elusive to oral drug therapy.
Ecole Polytechnique Federale Christian Heinis Manuel Merz Polytechnique Federale De Lausanne Nature Chemical Biology Professor Christian Heinis
Source: news-medical.net
Researchers receive two grants to study tuberculosis drug development
Weill Cornell Medicine researchers and the TB Drug Accelerator have received two grants totaling $6.8 million from the Bill & Melinda Gates Foundation to study tuberculosis (TB) drug development.
Michael Glickman Sabine Ehrt Carlf Nathan Dirk Schnappinger Laboratory Of Host World Health Organization
Source: news-medical.net
InnovationRx: Obamacare Enrollment Is Hitting New Highs
InnovationRx is your weekly digest of healthcare news. Sign up!
Source: forbes.com
Iktos and Bayer Announce Collaboration to expand the use of Artificial Intelligence to Design ...
Iktos and Bayer Announce Collaboration to expand the use of Artificial Intelligence to Design New Sustainable Crop Protection Solutions
Source: eagletribune.com
Lonza Group AG (OTCMKTS:LZAGY) Given Consensus Rating of "Moderate Buy" by Analysts
Lonza Group AG (OTCMKTS:LZAGY – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the five research firms that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and four have issued a buy rating on the company. Separately, Barclays began coverage on […]
Lonza Group Company Profile Analyst Recommendations For Lonza Group Lonza Group Price Performance Lonza Group News Ratings For Lonza Group Daily Capsules Health Ingredients
Source: etfdailynews.com
The Lipid Manufacturing Market CAGR to Exceed 11.8% by 2035, Due to Growing Demand of LNPs as Drug Delivery System| Roots Analysis
According to the recently published report by Roots Analysis, the growing demand for nanoparticle drug delivery systems with higher solubility is driving the lipid manufacturing market.Lipid Manufacturing Market OverviewThe global lipid nanoparticle manufacturing market is estimated to be worth USD 0.66 billion in 2...
United States Asia Pacific Fresenius Kabi Matinas Biopharma Gaurav Chaudhary Biotechnology Companies
Source: pharmiweb.com